ATE530569T1 - Assays zum nachweis von tuberkulose- antigenen, und impfstoffe - Google Patents

Assays zum nachweis von tuberkulose- antigenen, und impfstoffe

Info

Publication number
ATE530569T1
ATE530569T1 AT06774367T AT06774367T ATE530569T1 AT E530569 T1 ATE530569 T1 AT E530569T1 AT 06774367 T AT06774367 T AT 06774367T AT 06774367 T AT06774367 T AT 06774367T AT E530569 T1 ATE530569 T1 AT E530569T1
Authority
AT
Austria
Prior art keywords
antigens
vaccines
assay
detection
tuberculosis antigens
Prior art date
Application number
AT06774367T
Other languages
English (en)
Inventor
Antonio Campos-Neto
Suely Kashino
Original Assignee
Forsyth Dental In Ry For Children Fa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forsyth Dental In Ry For Children Fa filed Critical Forsyth Dental In Ry For Children Fa
Application granted granted Critical
Publication of ATE530569T1 publication Critical patent/ATE530569T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
AT06774367T 2005-07-01 2006-06-29 Assays zum nachweis von tuberkulose- antigenen, und impfstoffe ATE530569T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69643905P 2005-07-01 2005-07-01
US71706205P 2005-09-14 2005-09-14
PCT/US2006/025620 WO2007005627A2 (en) 2005-07-01 2006-06-29 Tuberculosis antigen detection assays and vaccines

Publications (1)

Publication Number Publication Date
ATE530569T1 true ATE530569T1 (de) 2011-11-15

Family

ID=37504020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06774367T ATE530569T1 (de) 2005-07-01 2006-06-29 Assays zum nachweis von tuberkulose- antigenen, und impfstoffe

Country Status (6)

Country Link
US (2) US7968694B2 (de)
EP (2) EP2305701A1 (de)
CN (1) CN101365714A (de)
AT (1) ATE530569T1 (de)
BR (1) BRPI0613168A2 (de)
WO (1) WO2007005627A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29858A (id) * 1998-11-04 2001-10-18 Isis Innovation Uji diagnostik tuberkulosis
EP2441493B1 (de) * 2006-03-14 2014-05-07 Oregon Health and Science University Verfahren zur Erzeugung einer Immunantwort auf Tuberculosis
EP2438173A4 (de) * 2009-06-05 2012-10-31 Univ Ohio State Res Found Biomaterialien, zusammensetzungen und verfahren
CN102653554B (zh) * 2011-04-22 2013-12-04 中国医学科学院病原生物学研究所 功能性结核分枝杆菌抗原多肽及其应用
CN102590502B (zh) * 2012-01-11 2014-07-02 北京市结核病胸部肿瘤研究所 辅助诊断结核病患者的试剂盒
CN104272111B (zh) * 2012-01-27 2017-10-03 豌豆属植物研究所股份公司 检测结核的方法
WO2015164617A1 (en) * 2014-04-24 2015-10-29 Somalogic, Inc. Tuberculosis biomarkers in urine and uses thereof
CN105181837A (zh) * 2015-08-28 2015-12-23 程永娟 一种结核分枝杆菌检测方法
CN108267588B (zh) * 2016-12-30 2020-10-23 首都医科大学附属北京胸科医院 结核分枝杆菌蛋白在制备诊断结核潜伏感染者和/或活动性肺结核产品中的用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4612132A (en) 1984-07-20 1986-09-16 Chevron Research Company Modified succinimides
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
CA2070281C (en) 1989-12-20 2005-08-23 David Allen Hafler Improved treatment of autoimmune diseases by aerosol administration of auto antigens
AU643141B2 (en) 1991-03-15 1993-11-04 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
US5643873A (en) 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
DK0671948T3 (da) 1992-06-25 1997-09-01 Smithkline Beecham Biolog Vaccinepræparat indeholdende adjuvanser
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US5654276A (en) 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5837490A (en) 1996-06-17 1998-11-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6544522B1 (en) 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6613881B1 (en) 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
US6183957B1 (en) * 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
US6294328B1 (en) * 1998-06-24 2001-09-25 The Institute For Genomic Research DNA sequences for strain analysis in Mycobacterium tuberculosis
CA2430896A1 (en) 2000-12-13 2002-06-20 Argonex Pharmaceuticals, Inc. Mhc class i associated peptides for prevention and treatment of tuberculosis
US6858213B2 (en) * 2001-04-20 2005-02-22 The Regents Of The University Of California Mycobacterial sulfation pathway proteins and methods of use thereof
EP2196473A1 (de) 2001-07-04 2010-06-16 Health Protection Agency Während der Latenz exprimierten Antigene aus Mycobacterium
GB0124593D0 (en) * 2001-10-12 2001-12-05 Microbiological Res Authority Mycobacterial antigens expressed under high oxygen tension
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis

Also Published As

Publication number Publication date
EP1910410B1 (de) 2011-10-26
BRPI0613168A2 (pt) 2010-12-21
US20070036816A1 (en) 2007-02-15
EP2305701A1 (de) 2011-04-06
CN101365714A (zh) 2009-02-11
EP1910410A2 (de) 2008-04-16
US20110268758A1 (en) 2011-11-03
US7968694B2 (en) 2011-06-28
WO2007005627A2 (en) 2007-01-11
WO2007005627A8 (en) 2008-10-16
WO2007005627A3 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
CY1118943T1 (el) Anti-pd-l1 αντισωματα και χρηση αυτων για την ενισχυση της λειτουργιας τ-κυτταρων
CY1118880T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE602006020300D1 (de) Immunologische verwendungen von immunmodulatorischen verbindungen für einen impfstoff und therapie gegen infektionskrankheiten
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
EA201590184A1 (ru) Вакцина на основе микобактериальных антигенов
Muehling et al. Circulating memory CD4+ T cells target conserved epitopes of rhinovirus capsid proteins and respond rapidly to experimental infection in humans
CY1112342T1 (el) Χιμαιρικα, υβριδικα και διαδοχικα πολυπεπτιδια μηνιγγοκοκκικου νμβ1870
BR112012003064B8 (pt) anticorpo ou fragmento de ligação de antígeno do mesmo, combinação que os compreende, método de detecção de infecção por rsv, moléculas de ácido nucléico, e método de produção de um anticorpo ou fragmento de ligação de antígeno do mesmo
BR112014023063A2 (pt) anticorpos que neutralizam rsv, mpv e pvm e usos dos mesmos
ATE530569T1 (de) Assays zum nachweis von tuberkulose- antigenen, und impfstoffe
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE495271T1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
GB0706558D0 (en) Diagnostic assay
DE602006013143D1 (de) Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate
ATE545708T1 (de) Krebsantigen mage-a9 und verwendungen davon
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2008077511A8 (en) Human polyomavirus and methods of diagnosis and treatment
WO2010108245A3 (pt) Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose
ATE395356T1 (de) Oberflächenprotein aus neisserien
WO2013134577A3 (en) Leishmaniasis antigen detection assays and vaccines
RU2014128849A (ru) Способ диагностики гастроэзофагельной рефлюксной болезни у детей
MY187887A (en) Strongyloides stercoralis protein and/or corresponding dna and rna sequences for application in diagnosis
TW201901152A (zh) 評估個體之登革熱病毒感染嚴重程度的方法
DE602005020428D1 (de) Sequenzen des schnabel- und federkrankheit-virus, zusammensetzungen und impfstoffe und deren verwendung in der therapie, der diagnose und in assays
BRPI0705395B8 (pt) sistema de detecção de anticorpos contra o parvovírus humano b19 utilizando antígenos, método de obtenção dos antígenos e uso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties